Practice Fusion Names Seasoned Health IT Executive Bevey Miner as New Chief Marketing Officer by Carolyn Helms | Apr 5, 2017 | Portfolio News
Jazz Pharmaceuticals Reaches Settlement with Hikma Pharmaceuticals Related to Xyrem Patent Litigation by Carolyn Helms | Apr 5, 2017 | Portfolio News
Zavante Therapeutics’ ZOLYD™ Met Primary Endpoint in Pivotal ZEUS Study for Treatment of Complicated Urinary Tract Infections by Carolyn Helms | Apr 5, 2017 | Portfolio News
Practice Fusion Names Seasoned Health IT Executive Bevey Miner as New Chief Marketing Officer by Carolyn Helms | Apr 5, 2017 | Portfolio News
Jazz Pharmaceuticals Completes Rolling Submission of New Drug Application for Vyxeos™ (CPX-351), an Investigational Treatment for Acute Myeloid Leukemia by Carolyn Helms | Apr 3, 2017 | Portfolio News
